USFDA APPLICATION NUMBER - 208647 / DOSAGE - CAPSULE;ORAL - EQ 5MG BASE
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
ROSUVASTATIN CALCIUM(UNII: 83MVU38M7Q) (ROSUVASTATIN - UNII:413KH5ZJ73) | ROSUVASTATIN | 40mg | 20mg | 10mg | 5mg |
Inactive Ingredients
Ingredient Name | Sun Pharmaceutical Industries, Inc. |
---|---|
AMMONIA(5138Q19F1X) | |
BUTYL ALCOHOL(8PJ61P6TS3) | |
CROSPOVIDONE(2S7830E561) | |
D&C RED NO. 28(767IP0Y5NH) | |
FD&C BLUE NO. 1(H3R47K3TBD) | |
FD&C GREEN NO. 3(3P3ONR6O1S) | |
FD&C RED NO. 3(PN2ZH5LOQY) | |
FD&C RED NO. 40(WZB9127XOA) | |
FERRIC OXIDE YELLOW(EX438O2MRT) | |
FERROSOFERRIC OXIDE(XM0M87F357) | |
GELATIN, UNSPECIFIED(2G86QN327L) | |
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |
MAGNESIUM OXIDE(3A3U0GI71G) | |
MANNITOL(3OWL53L36A) | |
MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | |
POTASSIUM HYDROXIDE(WZH3C48M4T) | |
PROPYLENE GLYCOL(6DC9Q167V3) | |
SHELLAC(46N107B71O) | |
SILICON DIOXIDE(ETJ7Z6XBU4) | |
SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) | |
SODIUM LAURYL SULFATE(368GB5141J) | |
TITANIUM DIOXIDE(15FIX9V2JP) |
LOOKING FOR A SUPPLIER?